Nano Lipid Carriers: A Novel Approach for Nose to Brain Drug Delivery

Bhavishya      Tyagi; Madhu      Verma

doi:10.2174/012210299X260333231120025251

Abstract

Background: A nanostructured lipid carrier (NLC) is a nanoparticulate carrier system consisting of solid lipids, liquid lipids, surfactants, and water. NLCs are second-generation lipid nanocarriers, gained continuous significance in recent times, and possess better physical stability, increased drug loading, improved permeability, and bioavailability. They are considered superior to many other traditional lipid-based nanocarriers such as nanoemulsion, liposomes, and solid lipid nanoparticles (SLN) and have emerged as an alternative to first-generation nanoparticles (SLN). NLCs have significant potential in the pharmaceutical industry due to their extensive beneficial effects, like drug targeting, enhanced bioavailability, and their wide positive benefits.

Objective: The primary aim of this review was to study and explore the Nano lipid carrier, its advantages, patent preferences, and advancement of NLCs use in nose-to-brain drug delivery.

Methods: The objective of this study was to conduct a literature review on the development of NLC for nose-to-brain drug delivery. The review focused on NLC, its significant role in nose-to-brain delivery, and relevant patents. To achieve this goal, different review articles searched, were studied, and summarized from various sources such as research articles, review articles, books, scientific reports, and patents.

Conclusion: This review article discusses the potential benefits of NLCs in brain-targeting drug delivery through the intranasal route and key aspects of NLCs, including their structure composition, formulation technique, and characterization, which are crucial for developing a reliable drug delivery.

[1]
Lee, D.; Minko, T. Nanotherapeutics for nose-to-brain drug delivery: An approach to bypass the blood-brain barrier. Pharmaceutics,  2021, 13(12), 2049.
 [http://dx.doi.org/10.3390/pharmaceutics13122049] [PMID: 34959331]

[2]
Selvaraj, K.; Gowthamarajan, K.; Karri, V.V.S.R. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif. Cells Nanomed. Biotechnol.,  2017, 46(8), 1-8.
 [http://dx.doi.org/10.1080/21691401.2017.1420073] [PMID: 29282995]

[3]
Kumar, M.; Misra, A.; Babbar, A.K.; Mishra, A.K.; Mishra, P.; Pathak, K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm.,  2008, 358(1-2), 285-291.
 [http://dx.doi.org/10.1016/j.ijpharm.2008.03.029] [PMID: 18455333]

[4]
Savale, S.; Mahajan, H. Nose to Brain: A versatile mode of drug delivery system. Asian J. Biomater. Res.,  2017, 3(1), 16-38.

[5]
Wermeling, DP System and method for intranasal administration of lorazepam.. US Patent 0055571A1, 2001.

[6]
Wermeling, DP System and method for intranasal administration of lorazepam. US Patent 6610271B2, 2003.

[7]
Choi, YM; Kim, KH Transnasal microemulsions containing diazepam.. WO Patent 04110403A1, 2004.

[8]
Choi, YM; Kim, KH Transnasal microemulsions containing diazepam. US Patent 0002987A1, 2005.

[9]
Misra, A; Vyas, TK Drugs loaded nasoadhesive microemulsions for brain targeted brisk delivery in acute epilepsy. Patent 1061/MUM/2004, 2005.

[10]
Misra, A; Vyas, TK Sedatives loaded intranasal nasoadhesive microemulsions for brain targeted delivery in insomnia. Patent 1124/MUM/2004, 2005.

[11]
Misra, A; Vyas, TK Drugs loaded intranasal nasoadhesive microemulsions for brain targeted delivery in migraine. Patent 1125/MUM/2004, 2005.

[12]
Frenkel, D; Maron, R; Burt, D; Weiner, HL Compositions and methods for treating neurological disorders. US Patent 0229233A1, 2006.

[13]
Castile, JD; Cheng, YH; Jenkins, PG Intranasal compositions. US Patent 0140981A1, 2007.

[14]
Mukherjee, S.; Ray, S.; Thakur, R.S. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J. Pharm. Sci.,  2009, 71(4), 349-358.
 [http://dx.doi.org/10.4103/0250-474X.57282] [PMID: 20502539]

[15]
Abdellatif, A.A.H.; Alsowinea, A.F. Approved and marketed nanoparticles for disease targeting and applications in COVID-19. Nanotechnol. Rev.,  2021, 10(1), 1941-1977.
 [http://dx.doi.org/10.1515/ntrev-2021-0115]

[16]
Elmowafy, M.; Al-Sanea, M.M. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharm. J.,  2021, 29(9), 999-1012.
 [http://dx.doi.org/10.1016/j.jsps.2021.07.015] [PMID: 34588846]

[17]
Garg, J.; Pathania, K.; Sah, S.P.; Pawar, S.V. Nanostructured lipid carriers: A promising drug carrier for targeting brain tumours. Future J. Pharm. Sci.,  2022, 8(1), 25.
 [http://dx.doi.org/10.1186/s43094-022-00414-8]

[18]
Ahmad, J.; Rizwanullah, M.; Amin, S.; Warsi, M.H.; Ahmad, M.Z.; Barkat, M.A. Nanostructured Lipid Carriers (NLCs): Nose-to-brain delivery and theranostic application. Curr. Drug Metab.,  2020, 21(14), 1136-1143.
 [http://dx.doi.org/10.2174/1389200221666200719003304] [PMID: 32682366]

[19]
Patidar, A.; Thakur, D.S.; Kumar, P.; Verma, J. A review on novel lipid based nanocarriers. Int. J. Pharm. Pharm. Sci.,  2010, 2(4), 30-35.

[20]
Tej, K.V.M.S.; Moin, A.; Gowda, D.V.; Karunakar, G.; Patel, N.P.; Kamal, S.S. Nanostructured lipid carrier-based drug delivery system. J. Chem. Pharm. Res.,  2016, 8(2), 627-643.

[21]
Jaiswal, P.; Gidwani, B.; Vyas, A. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif. Cells Nanomed. Biotechnol.,  2016, 44(1), 27-40.
 [http://dx.doi.org/10.3109/21691401.2014.909822] [PMID: 24813223]

[22]
Amit, S.; Ashish, B. Nanostructured Lipid Carriers: A review. J. Dev. Drugs,  2018, 7(1), 1-12.
 [http://dx.doi.org/10.4172/2329-6631.1000191]

[23]
kaur, S.; Nautyal, U.; Singh, R.; Singh, S.; Devi, A. Nanostructure Lipid Carrier (NLC): the new generation of lipid nanoparticles. Asian Pac. J. Health Sci.,  2015, 2(2), 76-93.
 [http://dx.doi.org/10.21276/apjhs.2015.2.2.14]

[24]
Chandana, K.V.; Gupta, N.V.; Kanna, S. Nanostructured lipid carriers: The frontiers in drug delivery. Asian J. Pharm. Clin. Res.,  2019, 12(7), 8-12.
 [http://dx.doi.org/10.22159/ajpcr.2019.v12i7.33595]

[25]
Chauhan, I.; Yasir, M.; Verma, M.; Singh, A.P. Nanostructured lipid carriers: A ground breaking approach for Transdermal drug delivery. Adv. Pharm. Bull.,  2020, 10(2), 150-165.
 [http://dx.doi.org/10.34172/apb.2020.021] [PMID: 32373485]

[26]
Hung, L.C.; Basri, M.; Tejo, B.A.; Ismail, R.; Nang, H.L.L.; Hassan, H.A.; May, C.Y. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Colloids Surf. B Biointerfaces,  2011, 87(1), 180-186.
 [http://dx.doi.org/10.1016/j.colsurfb.2011.05.019] [PMID: 21652183]

[27]
Patil, N.L.; Mahajan, H.S. Quercetin loaded nanostructured lipid carriers for nose to brain delivery: in vitro and in vivo studies. Am. J. Adv. Drug Deliv.,  2018, 6(01), 009-020.
 [http://dx.doi.org/10.21767/2321-547X.1000022]

[28]
Praveen, S.; Gowda, D.V.; Srivastava, A.; Osmani, R. Formulation and evaluation of Nanostructured Lipid Carrier (NLC) for Glimperide. Pharm. Lett.,  2016, 8(7), 251-256.

[29]
Emanet, M.; Şen, Ö.; Pignatelli, F.; Lavarello, C.; Petretto, A.; Ciofani, G. Hazelnut extract-loaded nanostructured lipid carriers and evaluation of their antioxidant properties. Front. Bioeng. Biotechnol.,  2022, 10, 953867.
 [http://dx.doi.org/10.3389/fbioe.2022.953867] [PMID: 35992355]

[30]
Lin, Y.K.; Huang, Z.R.; Zhuo, R.Z.; Fang, J.Y. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomedicine,  2010, 5, 117-128.
 [PMID: 20309398]

[31]
Ahmad, A.; Abuzinadah, M.F.; Alkreathy, H.M.; Banaganapalli, B.; Mujeeb, M. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies. PLoS One,  2018, 13(3), e0193451.
 [http://dx.doi.org/10.1371/journal.pone.0193451] [PMID: 29558494]

[32]
Masjedi, M.; Azadi, A.; Heidari, R.; Mohammadi-Samani, S. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation. J. Pharm. Pharmacol.,  2020, 72(10), 1341-1351.
 [http://dx.doi.org/10.1111/jphp.13316] [PMID: 32579251]

[33]
Piazzini, V.; Lemmi, B.; D’Ambrosio, M.; Cinci, L.; Luceri, C.; Bilia, A.; Bergonzi, M. Nanostructured lipid carriers as promising delivery system for plant extracts: The case of silymarin. Appl. Sci.,  2018, 8(7), 1163.
 [http://dx.doi.org/10.3390/app8071163]

[34]
Yuan, H.; Wang, L.L.; Du, Y.Z.; You, J.; Hu, F.Q.; Zeng, S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B Biointerfaces,  2007, 60(2), 174-179.
 [http://dx.doi.org/10.1016/j.colsurfb.2007.06.011] [PMID: 17656075]

[35]
Yu, S.; Tan, G.; Liu, D.; Yang, X.; Pan, W. Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies. RSC Advances,  2017, 7(27), 16668-16677.
 [http://dx.doi.org/10.1039/C7RA00552K]

[36]
Puglia, C.; Sarpietro, M.G.; Bonina, F.; Castelli, F.; Zammataro, M.; Chiechio, S. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers. J. Pharm. Sci.,  2011, 100(5), 1892-1899.
 [http://dx.doi.org/10.1002/jps.22416] [PMID: 21374621]

[37]
Khosa, A.; Reddi, S.; Saha, R.N. Nanostructured lipid carriers for site-specific drug delivery. Biomed. Pharmacother.,  2018, 103, 598-613.
 [http://dx.doi.org/10.1016/j.biopha.2018.04.055]

[38]
Javed, S.; Mangla, B.; Almoshari, Y.; Sultan, M.H.; Ahsan, W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnol. Rev.,  2022, 11(1), 1744-1777.
 [http://dx.doi.org/10.1515/ntrev-2022-0109]

[39]
J, N.; Karri, V.V.S.R. Anindita De. Nanostructured lipid carrier (NLC): A promising drug delivery system. GJN,  2017, 1(5), 00120-00125.
 [http://dx.doi.org/10.19080/GJN.2017.01.555575]

[40]
Gowda, D.V.; Tej, K.V.M.S.; Moin, A. Nano structured lipid carrier based drug delivery system. J. Chem. Res.,  2016, 8(2), 627-643.

[41]
Wong, H.L.; Li, Y.; Bendayan, R.; Rauth, M.A.; Wu, X.Y. Solid lipid nanoparticles for anti-tumor drug delivery. Amiji, MM In: Nanotechnology for Cancer Therapy; CRC press, Taylor & Francis Group: Boca Raton, 2007. 

[42]
Iqbal, M.A.; Md, S.; Sahni, J.K.; Baboota, S.; Dang, S.; Ali, J. Nanostructured lipid carriers system: Recent advances in drug delivery. J. Drug Target.,  2012, 20(10), 813-830.
 [http://dx.doi.org/10.3109/1061186X.2012.716845] [PMID: 22931500]

[43]
Shah, N.V.; Seth, A.K.; Balaraman, R.; Aundhia, C.J.; Maheshwari, R.A.; Parmar, G.R. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. J. Adv. Res.,  2016, 7(3), 423-434.
 [http://dx.doi.org/10.1016/j.jare.2016.03.002] [PMID: 27222747]

[44]
Schiller, R.; Weiss, C.K.; Landfester, K. Phase stability and photocatalytic activity of Zr-doped anatase synthesized in miniemulsion. Nanotechnology,  2010, 21(40), 405603.
 [http://dx.doi.org/10.1088/0957-4484/21/40/405603] [PMID: 20829575]

[45]
Kumar, M.; Amandeep; Bhatt, S.; Devi, S.; Upadhyay, P.K.; Saini, V.; Mittal, A.; Mehan, N.; Saini, A. Recent advances in the development of the nanostructured lipid carriers for the topical fungal infections. J. Rep. Pharm. Sci.,  2020, 9(2), 271-278.
 [http://dx.doi.org/10.4103/jrptps.JRPTPS_99_19]

[46]
Loo, Ch.; Basri, M.; Ismail, R.; Lau, H.; Tejo, B.A.; Kanthimathi, M.S.; Hassan, H.; Choo, Y. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int. J. Nanomedicine,  2012, 8, 13-22.
 [http://dx.doi.org/10.2147/IJN.S35648] [PMID: 23293516]

[47]
Lu, G.W.; Gao, P. Emulsions and micro emulsions for topical and transdermal drug delivery. In: Handbook of Non-Invasive Drug Delivery Systems, 1st ed; Kulkarni, V.S., Ed.; William Andrew: UK, 2010. 
 [http://dx.doi.org/10.1016/B978-0-8155-2025-2.10003-4]

[48]
Subramaniam, B.; Siddik, Z.H.; Nagoor, N.H. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J. Nanopart. Res.,  2020, 22(6), 141.
 [http://dx.doi.org/10.1007/s11051-020-04848-0]

[49]
Uprit, S.; Kumar Sahu, R.; Roy, A.; Pare, A. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm. J.,  2013, 21(4), 379-385.
 [http://dx.doi.org/10.1016/j.jsps.2012.11.005] [PMID: 24227958]

[50]
Madane, R.G.; Mahajan, H.S. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Drug Deliv.,  2016, 23(4), 1326-1334.
 [http://dx.doi.org/10.3109/10717544.2014.975382] [PMID: 25367836]

[51]
Imran, M.; Shah, M.R.; Ullah, S. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis; Elsevier: UK, 2017. 

[52]
Kuntsche, J.; Horst, J.C.; Bunjes, H. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int. J. Pharm.,  2011, 417(1-2), 120-137.
 [http://dx.doi.org/10.1016/j.ijpharm.2011.02.001] [PMID: 21310225]

[53]
Ahmad, J. Lipid nanoparticles based cosmetics with potential application in alleviating skin disorders. Cosmetics,  2021, 8(3), 84.
 [http://dx.doi.org/10.3390/cosmetics8030084]

[54]
Kaul, S.; Gulati, N.; Verma, D.; Mukherjee, S.; Nagaich, U. Role of nanotechnology in cosmeceuticals: A review of recent advances. J. Pharm.,  2018, 2018, 1-19.
 [http://dx.doi.org/10.1155/2018/3420204] [PMID: 29785318]

[55]
Puri, D.; Bhandari, A.; Sharma, P.; Choudhary, D. Lipid nanoparticles (SLN, NLC): A novel approach for cosmetic and dermal pharmaceutical. Int. J. of Pharm. Life Sci.,  2016, 7(9), 5177-5184.

[56]
Fox, CB; Khandhar, AP; Van, H.N; Erasmus, JG; Lin, SS. Nanostructured lipid carriers and stable emulsions and uses thereof. EP Patent 3638207, 2020.

[57]
Pathania, A; Kumar, M; Sarup, P; Bhatt, S; Pandurangan, A; Saini, V Novel nanostructured lipid carrierbased ophthalmic controlled release formulation for treatment in fungal keratitis. Patent IN201811021213, 2019.

[58]
Sarmidi, MR; Mohamad, ST; Hasham, R A nanostructured lipid carrier encapsulates bromelain extract. MYPI Patent 2018300001, 2019.

[59]
Behl, G; Kumari, S Ocular drug delivery. WO Patent 2019123420A1, 2019.

[60]
Wang, B; Wang, Q; Bai, L. A kind of polymer thermal sensitive liposome loading yeast dextran and carnosic acid. CN Patent 108904450, 2018.

[61]
Hasham, R; Suhaimi, SH; Rosli, NA; Aziz, R; Sarmidi, MR A nanostructured lipid carrier encapsulates orthosiphon stamineus extract. MYPI Patent 2016300023, 2018.

[62]
Aziz, R; Sabtu, R; Arifffin, FD; Rosli, NA; Aziz, A.A; Hasham, RA. Nanostructured lipid carrier encapsulates zingiber officinale oil. MYUI Patent 2015002695, 2017.

[63]
Hamidreza, K.; Majid, S. Topical nanodrug formulation. US Patent 20170020896, 2017.

[64]
Wang, S; Zhang, Y; Yin, L; Liang, Z Hydrophilic modification asiatic acid nanostructured lipid carrier and preparation method thereof. CN Patent 105919976, 2016.

[65]
Kaur, IP; Kakker, S; Singla, A Nanostructured lipidic-polymeric pharmaceutical composition encapsulating drugs. Patent IN2074/DEL/2014, 2016.

[66]
Salunkhe, SS; Bhatia, NM; Bharia, MS Idebenone lipid nanocarrier composition for the treatment of neurodegenerative disorders. Patent IN276/MUM/2014, 2015.

[67]
Tiange, C; Yu, C; Fengde, T. Psoralen-doxorubicin-loaded composite nanostructured lipid carrier preparation and preparation method thereof. CN Patent 104367549A, 2015.

[68]
Kang, Z. Podophyllotoxin preparation resisting condyloma acuminata relapse and HPV latent infection. Nanfang Hospital of Southern Medical University. CN Patent 103893167A, 2014.

[69]
Yazan, LS; Keat, NW; Abdullah, R; Wun, HC Thymoquinone loaded nanostructured lipid carriers (TQNLC) and uses thereof. MYPI Patent 2012001818, 2013.

[70]
Kaur, SK; Chetan, PM Nanotechnology based herbal composition for safe and effective treatment of psoriasis. Patent IN422/MUM/2011, 2013.

[71]
Qiang, X; Xueyang, D Composite anti-screening agent nanostructured lipid carrier and preparation method thereof. CN Patent 102688152A, 2012.

[72]
Qiang, X; Wujun, Z Resveratrol nanostructured lipid carrier and preparation method thereof. CN Patent 102614091, 2012.

[73]
Kadam, VT; Nanjwade, BK Nanostructured lipid carrier (NLC) drug delivery systems for treatment of neurodegenerative disorders. Patent IN1251/MUM/2012, 2012.

[74]
Ismal, R; Hung, L.C; Nang, HLL; May, CY; Basri, M.B; Tejo, BA. Method for preparing a nanostructured lipid carrier and a product manufactured by the same. KR Patent 1020110137263, 2011.

[75]
Dianrui, Z; Lejiao, J; Huiling, C; Cunxian, D; Yancai, W; Feifei, F Silybin nanostructured lipid barrier preparation method thereof. CN Patent 101632638, 2010.

[76]
Qiang, X; Hongxia, W. Coenzyme Q nano structured lipid carrier and preparation method thereof. CN Patent 101658468B, 2010.

[77]
Qiang, X; Jiaying, W Azithromycin nano structured lipid carrier and preparation method thereof. CN Patent 101658493, 2010.

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

For Visitors

DOI https://dx.doi.org/10.2174/012210299X260333231120025251	Print ISSN 2210-299X
Publisher Name Bentham Science Publisher	Online ISSN 2210-3007

Current Indian Science

Nano Lipid Carriers: A Novel Approach for Nose to Brain Drug Delivery

Abstract Play Pause

Related Journals

Related Books

Abstract